Health News

“More recently, in a Fox News videoRockland County executive Ed Day also identified “people from overseas” as the source of the measles outbreak. Day was asked by the Fox News reporter why he took the step to declare a medical state-of-emergency. Day answered:
“I took the step because we’ve been battling this for six months. Six months ago, we had seven infected individuals come from overseas to the local area in Rockland County.

“Researchers under Dr. Yankel Gabet of TAU’s Slacker Faculty of Medicine and the late Professor Itai Bab of Hebrew University’s Bone Laboratory, isolated the component cannabidiol (CBD) to see its effect on bone fractures. They found that when giving CBD to rats with mid-femoral fractures, the healing process of the bone was significantly sped up to about an eight-week recovery. The effects were still seen when tetrahydrocannabinol (THC), the molecule within cannabis that produces a “high” effect, was removed from CBD, making the potential for bone healing treatment without psychoactive effects a possibility.”

“A respected Brazilian neurologist is seeking to blow the lid off the “brain death” myth, saying it is being perpetuated to supply an international multi-billion-dollar transplant industry.

Doctor Cicero G. Coimbra, MD PhD, a neurologist and professor of neuroscience at the Federal University of São Paulo, Brazil, has also said recovery for comatose patients is often possible, but a tightly controlled medical establishment is not giving doctors and medical students the facts they need to “do the best they can” for their patients.”

“Here is what scientists have been saying recently about what they do and don’t know about measles and measles vaccine failures:

From the Vaccine Research Group at Minnesota’s Mayo Clinic:

“While the current vaccine used in the USA and many other countries is safe and effective, paradoxically in the unique case of measles, it appears to insufficiently induce herd immunity in the population;” 148

Even with two doses of MMR vaccine, an individual can fail to either mount or sustain a protective immune response. Up to 10 percent of those given two doses “fail to develop protective humoral immunity and those antibody levels wane over time, which can result in infection;” 149

Individuals respond differently to vaccination and each individual’s genes play a role in controlling measles vaccine-induced immune responses. Scientists still do not completely understand “how the immune response is generated” or “how host genetic and epigenetic variations change and impact vaccine immune responses,” or “how pathogens interact with the immune system.” 150

The importance of cellular immunity to vaccine-induced protection is not completely understood.” Some children with no detectible measles antibodies may still be protected against measles, which supports the “involvement of cellular immunity.” 151

“RESULTS: Complete remission (CDAI score,<150) was achieved by 5 of 11 subjects in the cannabis group (45%) and 1 of 10 in the placebo group (10%; P = .43). A clinical response (decrease in CDAI score of>100) was observed in 10 of 11 subjects in the cannabis group (90%; from 330± 105 to 152 ± 109) and 4 of 10 in the placebo group (40%; from 373 ± 94 to 306 ± 143; P = .028). Three patients in the cannabis group were weaned from steroid dependency. Subjects receiving cannabis reported improved appetite and sleep, with no significant side effects.

CONCLUSIONS: Although the primary end point of the study (induction of remission) was not achieved, a short course (8 weeks) of THC-rich cannabis produced significant clinical, steroid-free benefits to 10 of 11 patients with active Crohn’s disease, compared with placebo, without side effects. Further studies, with larger patient groups and a nonsmoking mode of intake, are warranted., NCT01040910.”

“Impressively, in a randomized, double-blind, placebo-controlled clinical trial of Crohn’s patients whose symptoms were resistant to steroids, immunomodulators, and anti-tumor necrosis factor-alpha agents, THC-rich cannabis induced complete remission in 45% of subjects compared to 10% who received placebo (45).

Further, a significant decrease in the Crohn’s Disease Activity Index (CDAI) was witnessed in 90% of those in the cannabis group versus 40% of controls (45). In addition to improvements in sleep and appetite, three patients in the THC group were able to taper off of steroid therapy (45). Although this study used marijuana cigarettes containing 115mg ofΔ9-tetrahydrocannabinol (THC), cannabis-containing baked goods, tinctures, sprays, teas, oils, and lozenges would circumvent exposure to combustion byproducts and prevent any smoking-associated deleterious health outcomes.”

“RESULTS: Within 2 months of starting DNT all six patients went into remission, with discontinuation of all pharmacological drugs. Three patients have remained in sustained remission for 4 to 8 years. One patient with very severe CD had recurrence of CD symptoms after being in complete remission for 18 months, one patient was in remission for 3 years but symptoms recurred when she became less compliant to DNT and one recently treated patient remains in remission after 6 months. With the addition of rhGH, the 4 growing patients had good-excellent growth response

CONCLUSION: DNT engendered prolonged remission and restoration of normal weight in moderate-severe juvenile CD patients, providing conditions that enabled rhGH to stimulate growth. These findings justify larger controlled trials to evaluate the long-term benefit of compliance to DNT in both juvenile and adult CD patients.”